Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | CETP | P11597 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.39 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.39 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3804139 | 0.87 | TSHR (0.59) | TSHRCETPALDH1A1LMNAMAPK1 | |
| SCHEMBL3804138 | 0.87 | TSHR (0.55) | TSHRCETPALDH1A1LMNAMAPK1 | |
| SCHEMBL3072372 | 0.84 | ALDH1A1 (0.61) | TSHRCETPALDH1A1LMNAMAPK1 | |
| SCHEMBL19509036 | 0.84 | ALDH1A1 (0.61) | TSHRCETPALDH1A1LMNAMAPK1 | |
| SCHEMBL31404912 | 0.83 | KMT2A (0.62) | TSHRALDH1A1LMNAMAPK1SLC6A2 | |
| SCHEMBL5379773 | 0.82 | TSHR (0.61) | TSHRCETPALDH1A1ELANE | |
| SCHEMBL13347322 | 0.81 | TSHR (0.49) | TSHRCETPALDH1A1LMNAMAPK1 | |
| SCHEMBL206609 | 0.80 | TSHR (0.68) | TSHRCETPALDH1A1ELANENPC1 | |
| SCHEMBL21189481 | 0.80 | ALDH1A1 (0.49) | TSHRCETPALDH1A1LMNAMAPK1 | |
| SCHEMBL16368191 | 0.80 | CETP (0.48) | TSHRCETPALDH1A1LMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190224220-A1 | Carbidopa and L-Dopa Prodrugs and Methods of Use | ABBVIE INC. (US) | 2019-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190224220-A1 | Carbidopa and L-Dopa Prodrugs and Methods of Use | COMT, SNCA, PARK7 | TSHR 1816/4885CETP 3250/4885ALDH1A1 694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.